Hans Christian Hagedorn

Hans Christian Hagedorn (6 September 1888 – 6 October 1971) was a Danish physician and biochemist known for his significant contributions to the field of diabetes treatment. He is best known for co-discovering NPH insulin (Neutral Protamine Hagedorn insulin), which became a cornerstone in diabetes management.

Early Life and Education

Hans Christian Hagedorn was born in Copenhagen, Denmark. He pursued his medical studies at the University of Copenhagen, where he developed an interest in biochemistry and endocrinology.

Career and Research

Hagedorn's career was marked by his dedication to improving the lives of people with diabetes. In 1922, he co-founded the Nordisk Insulinlaboratorium (now part of Novo Nordisk) with August Krogh, a Nobel laureate. This institution was pivotal in the production and distribution of insulin in Europe.

Discovery of NPH Insulin

One of Hagedorn's most notable achievements was the development of NPH insulin in 1946. This form of insulin, which combines insulin with the protein protamine, allows for a slower absorption rate, providing more stable blood glucose levels for patients. NPH insulin remains widely used in diabetes treatment today.

Legacy

Hagedorn's work has had a lasting impact on the field of diabetes care. The Hagedorn Research Institute, named in his honor, continues to be a leading center for diabetes research. His contributions have improved the quality of life for millions of people with diabetes worldwide.

Personal Life

Hagedorn was married and had children. He remained active in his research and professional activities until his death in 1971.

See Also

• Diabetes mellitus
• Insulin therapy
• Novo Nordisk
• August Krogh